Post-publication Peer Review (P3R) is an online forum for ongoingreview peer review. To submit a P3R please go to the article you wish to respond to and click on the link that reads "P3Rs: Submit a Response." Submission of P3Rs are open to all health care professionals and experts in related fields.

Post-publication Peer Reviews to:

REVIEW ARTICLES:
Mark Lebwohl, Lily Clark, and Jacob Levitt
Therapy for Head Lice Based on Life Cycle, Resistance, and Safety Considerations
Pediatrics 2007; 119: 965-974 [Abstract] [Full text] [PDF]
*P3Rs: Submit a response to this article

P3Rs published:

[Read P3R] Homonyms
Leonard Levy, M.D.   (4 May 2007)
[Read P3R] an ad disguised as a review article
Kelly D. Young   (18 June 2007)

Homonyms 4 May 2007
Next P3R Top
Leonard Levy, M.D.,
Pediatrician in private practice
N/A

Send letter to journal:
Re: Homonyms

llevy1{at}twcny.rr.com Leonard Levy, M.D.

"The former faired worse than malathion applied at days 0 and 7,36 whereas the latter faired better compared with malathion or permethrin single-use therapy. "

I don't think the authors intended to use the word "fair." I'm also fairly sure that Pediatrics employs editors.

Leonard Levy, MD 6836 E. Genesee Street Fayetteville, NY 13066

Conflict of Interest:

None declared
an ad disguised as a review article 18 June 2007
Previous P3R Top
Kelly D. Young,
Pediatric Emergency Physician
David Geffen School of Medicine, Harbor-UCLA Medical Center

Send letter to journal:
Re: an ad disguised as a review article

kyoung{at}emedharbor.edu Kelly D. Young

I was astounded to read this obviously biased article in Pediatrics. While it is entirely possible that Ovide should be the preferred treatment for head lice, I am unable to discern what information to trust at face value, since the article is written by someone who is a major shareholder and vice president of the company that makes and sells Ovide for $125 per bottle. I am surprised that Pediatrics allowed a pharmaceutical company to basically write a 9 page ad in the guise of a review article. As I first read the article, I thought to myself, "Wow, this sounds like someone involved with Ovide wrote it," but I never thought that would actually be true. AFTER I read the article, I looked at the title and saw the disclosure in itsy bitsy font, and realized that I had just wasted my time reading this article.

Conflict of Interest:

None declared